For: | Kuo MJ, Chen HH, Chen CL, Fann JCY, Chen SLS, Chiu SYH, Lin YM, Liao CS, Chang HC, Lin YS, Yen AMF. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening. World J Gastroenterol 2016; 22(12): 3460-3470 [PMID: 27022228 DOI: 10.3748/wjg.v22.i12.3460] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i12/3460.htm |
Number | Citing Articles |
1 |
Benjamin Cadier, Julie Bulsei, Pierre Nahon, Olivier Seror, Alexis Laurent, Isabelle Rosa, Richard Layese, Charlotte Costentin, Carole Cagnot, Isabelle Durand‐Zaleski, Karine Chevreul. Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States. Hepatology 2017; 65(4): 1237 doi: 10.1002/hep.28961
|
2 |
Xueying Wang, Yangyu Zhang, Na Yang, Hua He, Xuerong Tao, Changgui Kou, Jing Jiang. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5087643
|
3 |
V.V. Petkau, E.N. Bessonova, V.V. Breder, M.A. Anashkina. Preliminary findings of hepatocellular carcinoma screening in the at-risk population. Dokazatel'naya gastroenterologiya 2023; 12(4): 54 doi: 10.17116/dokgastro20231204154
|
4 |
Jui-Kun Chiang, Lin Chih-Wen, Yee-Hsin Kao. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open 2017; 7(6): e015936 doi: 10.1136/bmjopen-2017-015936
|
5 |
Anh Le Tuan Nguyen, Hoa Thi Thu Nguyen, Kwang Chien Yee, Andrew J. Palmer, Christopher Leigh Blizzard, Barbara de Graaff. A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening Strategies. Value in Health 2021; 24(5): 733 doi: 10.1016/j.jval.2020.11.014
|
6 |
Yun-Wei Yan, Xin-Kui Liu, Shun-Xiang Zhang, Qing-Feng Tian. Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China. World Journal of Gastrointestinal Oncology 2023; 15(5): 858 doi: 10.4251/wjgo.v15.i5.858
|
7 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
8 |
Hanne Åström, Nelson Ndegwa, Hannes Hagström. External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population. JHEP Reports 2021; 3(5): 100343 doi: 10.1016/j.jhepr.2021.100343
|
9 |
Yun-Wei Yan, Xin-Kui Liu, Shun-Xiang Zhang, Qing-Feng Tian. Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China. World Journal of Gastrointestinal Oncology 2023; 15(5): 859-877 doi: 10.4251/wjgo.v15.i5.859
|
10 |
Miquel Serra-Burriel, Isabel Graupera, Pere Torán, Maja Thiele, Dominique Roulot, Vincent Wai-Sun Wong, Indra Neil Guha, Núria Fabrellas, Anita Arslanow, Carmen Expósito, Rosario Hernández, Grace Lai-Hung Wong, David Harman, Sarwa Darwish Murad, Aleksander Krag, Guillem Pera, Paolo Angeli, Peter Galle, Guruprasad P. Aithal, Llorenç Caballeria, Laurent Castera, Pere Ginès, Frank Lammert. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia. Journal of Hepatology 2019; 71(6): 1141 doi: 10.1016/j.jhep.2019.08.019
|
11 |
Seng-Howe Nguang, Cheng-Kun Wu, Chih-Ming Liang, Wei-Chen Tai, Shih-Cheng Yang, Ming-Kun Ku, Lan-Ting Yuan, Jiunn-Wei Wang, Kuo-Lun Tseng, Tsung-Hsing Hung, Pin-I Hsu, Deng-Chyang Wu, Seng-Kee Chuah, Chien-Ning Hsu. Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan. International Journal of Environmental Research and Public Health 2018; 15(12): 2655 doi: 10.3390/ijerph15122655
|